Multivalent nanomedicines to treat COVID-19: A slow train coming
Tanveer A. Tabish, Michael R. Hamblin
Topics & Concepts
NanomedicineCoronavirus disease 2019 (COVID-19)Collateral damageCellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyBiologyCell biologyVirologyNanotechnologyMedicineDiseaseNanoparticleGeneticsMaterials scienceCriminologyPathologyInfectious disease (medical specialty)SociologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingAdvanced biosensing and bioanalysis techniques